CASE PRESENTATION
A 54-year-old man noted a mass at the left lower anterior neck 3 months previously. Physical examination revealed a mass (5 × 4 cm) on the left thyroid. The mass was firm and movable during swallowing. No cervical lymph node was palpable and the neck was not tender to palpation. Chest roentgenogram revealed that the trachea was displaced to the right. Thyroid ultrasonography showed a homogeneous and low echoic mass of 4.8 cm in diameter in the left lobe of the thyroid. Fine-needle aspiration biopsy (FNAC) was performed. Cytologic examination indicated papillary carcinoma and suggested operation. The serum concentrations of thyroxine, thyroid-stimulating hormone, and thyroglobulin were all normal. Computed tomography (CT) of the neck showed a soft tissue dense mass, which was located on the inferior left lobe of the thyroid gland and left upper mediastinum ( Figure 1 ). The mass displaced and compressed the trachea.
At operation, the tumor was a mass found to occupy the lower portion of the left thyroid lobe and extended to the anterior upper mediastinum. Complete resection of the tumor was successfully achieved by left thyroid lobectomy via a median sternotomy approach. Intraoperative findings showed that the wellcapsulated mass taken from the left thyroid gland was not adherent to the surrounding tissue. The thymus was inspected and palpation revealed a smooth surface. Therefore, a tumor arising from the thymus gland was excluded.
Microscopic examination revealed confluent nests and lobules of epithelioid and spindle-shaped cells with pleomorphic vesicular nuclei, distinct nucleoli with small lymphocytes and plasma cell infiltration, and focal squamous differentiation. Immunohistochemical tests showed that the tumor was positive for CD5, weakly positive for cytokeratin, and negative for thyroglobulin and vimentin ( Figure 2) .
The patient was treated by complete resection and received no adjunctive radiotherapy. The patient's postoperative course was uneventful. The metastatic follow-up was negative. After 36 months of follow-up, no evidence of recurrence was observed.
In the literature, a total of 25 cases of CASTLE have been reported. With our case, this number has increased to 26 (Table) [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . We examined the methods of surgery for CASTLE, and the method seems to be important in prognosis. Six patients were excluded from further study: for three, the tumors were excised, two had extrathyroid tumors, and one received radiotherapy alone. Of the remaining 19 patients, six patients underwent total thyroidectomy, seven patients underwent subtotal thyroidectomy, and seven patients underwent total thyroid lobectomy. The patients who underwent total thyroidectomy were cases with aggressive tumors and were difficult to manage. In this group, five showed locoregional recurrence and only one survived for 2 years without recurrence. Comparing the groups of subtotal thyroidectomy and total thyroid lobectomy, we noted that those who were treated by subtotal thyroidectomy had higher locoregional recurrence and distant metastasis rates than those treated by total thyroid lobectomy. Of the cases who underwent total thyroid lobectomy, only one case of lung metastasis before operation was noted. The remaining six cases survived without locoregional recurrence or distant metastasis. In addition, the patients treated by total thyroid lobectomy did not receive postoperative radiotherapy. There were four cases of locoregional recurrence, one case of distant metastasis and two cases without recurrence in the subtotal thyroidectomy group. The outcome of total thyroidectomy and lobectomy of treatment in CASTLE is uncertain and we need a larger series of patients to support our data. thymus into four groups: ectopic hamartomatous thymoma, ectopic cervical thymoma, spindle epithelial tumor with thymus-like differentiation (SETTLE), and CASTLE [4] . The first two are considered to be benign and have the same histologic features as thymoma. The last two should be considered malignant. SETTLE occurs in children and young adults, and often has a late distant recurrence [3] . During fetal development, thymus tissue is derived from the third and fourth branchial pouch, and descends with growth of the fetus and enters the mediastinum. These tumors arise from either ectopic thymus tissue or remnants of branchial pouches, which retain the potential to differentiate along the thymus line [1] . It is unknown why ectopic thymus tissue may develop into these tumor types. According to previous reports, CASTLE occurs with equal frequency in men and women. Tumors are located on the left side in approximately two-thirds of cases, particularly the lower portion of the thyroid gland. CASTLE often occurs in adults and frequently invades the adjacent soft tissue and metastasizes to the regional lymph nodes. These tumors recur in regional nodes after a long interval and the clinical course is rarely aggressive [1] .
DISCUSSION
Histologically, CASTLE shows a lobulated and expansive growth pattern, with fibrous septa dividing the tumor, large vesicular nuclei with prominent nucleoli, a low mitotic count, and may be associated with lymphoplasmacytic infiltration [1, 4, 5] . These tumors are similar to thymic carcinoma of lymphoepithelioma-like carcinoma or squamous cell carcinoma of thyroid, because they are high-grade malignant neoplasms [1, 4] .
Immunohistochemical studies can differentiate CASTLE from other malignant thyroid neoplasms [6] . CASTLEs are immunoreactive for cytokeratin protein, but not for calcitonin or thyroglobulin. Similar to thymic carcinoma, CASTLE is immunohistochemically positive for CD5, but the majority of thymomas or other malignancies are CD5-negative [12] .
On CT scan, the tumor usually shows a welldefined, soft tissue density, with slight enhancement after administration of contrast medium. Magnetic resonance imaging shows isointensity on T1-weighted images and hyperintensity on T2-weighted images [7] . FNAC of these tumors may also show spindle cells, although some reports showed nonspecific findings. Thus, FNA cytology has limited use for the diagnosis of CASTLE. Based on the reviewed literature, CASTLE can be diagnosed by exclusion. Histologic examination may also provide a definite diagnosis when performed by an experienced pathologist.
Surgical intervention in these tumors is challenging and should be reserved for patients with voice or vocal cord function. There are several possible postoperative morbidities, including cord palsy and aspiration pneumonia, which must be explained to the patient before operation. Median sternotomy is an excellent approach, even in cases with mediastinum and pulmonary involvement [13] . Complete resection of these tumors is very important to achieve satisfactory longterm survival. CASTLE with lymph node involvement has a high risk of recurrence when treated by both surgery and radiotherapy. Surgery alone is indicated for patients without lymph node metastasis. The role of radiotherapy when lymph node metastasis has occurred can limit subsequent recurrence, but there is no evidence for benefits from chemotherapy [8] .
In summary, CASTLE is a rare malignancy of the thyroid with fewer than 30 cases reported to date. This tumor is similar to anaplastic carcinoma or squamous cell carcinoma and definite diagnosis requires an experienced pathologist and positive CD5 immunoreactivity. It is important to differentiate this tumor from anaplastic carcinoma or squamous cell carcinoma, which have poor prognoses. Surgical excision with or without radiotherapy is the first choice. CASTLE with anterior mediastinum involvement is extremely rare. Surgical management of tumors involving the mediastinum is challenging and should be performed by a median sternotomy approach because of the need for complete resection of the tumor. Complete resection is important to improve the long-term survival rate and locoregional recurrence rate. Therefore, total thyroidectomy and total thyroid lobectomy are indicated 
